Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cervix carcinoma stage 0
ADR ID BADD_A05985
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.01      Cervix neoplasms malignant
16.12.01.002      Cervix carcinoma stage 0
21      Reproductive system and breast disorders
21.06      Cervix disorders (excl infections and inflammations)
21.06.02      Cervix neoplasms
21.06.02.002      Cervix carcinoma stage 0
Description Not Available
MedDRA Code 10061809
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma cervix in situ | Carcinoma in situ of cervix | Carcinoma in situ of cervix uteri | Carcinoma uterine cervix in situ | Cervical cancer stage 0 | Cervical carcinoma in situ | Cervix carcinoma in situ | CIS of cervix | In situ cancer of cervix | Uterine cervix carcinoma stage 0 | Cervical carcinoma stage 0 | Cervix carcinoma stage 0 | Papanicolaou smear abnormal, class IV a | Papanicolaou smear abnormal, class IV b
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01281Levonorgestrel0.006254%
BADD_D02464Fingolimod0.005790%
The 1th Page    1    Total 1 Pages